博客

丙型肝炎

Harvoni:治疗慢性丙型肝炎的抗病毒药物

Harvoni patient's highlighted liver

Harvoni is a prescription-only medication used to treat chronic hepatitis C in adults and children aged 3 and above. Harvoni is an antiviral drug that is taken once a day orally. 

Harvoni Treatment Info

获得事先授权
(877) 778-0318

Sofosbuvir and ledipasvir are the two active components. Ledipasvir blocks a protein called HCV NS5A necessary for the multiplication of the hepatitis C virus. Sofosbuvir interferes with the reproduction of the genetic material required for the replication of the virus.

What Is Harvoni?

Harvoni is an FDA-approved direct-acting antiviral medication used to treat various forms of hepatitis C.

Before taking this medication, it is crucial to tell your doctor and pharmacist:

  • If you are allergic to any drug, especially sofosbuvir or ledipasvir.
  • If you have any disorders such as liver issues, hepatitis B, or diabetes.
  • If you take any prescription, over-the-counter, or herbal drugs.
  • If you are breastfeeding, pregnant, or planning to become pregnant. Harvoni’s safety during pregnancy and breastfeeding is unknown. Contact your doctor and pharmacist about the risk-benefit ratio of taking Harvoni.

What Is Harvoni Used To Treat?

Harvoni is used to treat hepatitis C, a chronic viral infection that causes inflammation in the liver. It is suggested for adults and children over the age of three who have chronic hepatitis C with or without cirrhosis.

Hepatitis C genotypes are six distinct species or strains of the virus. Harvoni is used to treat a variety of hepatitis C virus genotypes, including genotypes 1, 4, 5, and 6.

How Does Harvoni Work?

Harvoni works by inhibiting the proteins required for hepatitis C virus growth and replication. It also prevents the hepatitis C virus from reproducing its genetic material, stopping the infection from growing.

Both of the active components of Harvoni, sofosbuvir and ledipasvir, have a role in the treatment of hepatitis C.

Ledipasvir works by interfering with a protein called HCV NS5A, which is involved in viral replication. Sofosbuvir prevents the replication of genetic material by inhibiting an RNA-dependent polymerase known as HCV NS5B, which is required for the virus’s proliferation and replication.

How Is Harvoni Administered?

  • Harvoni should be taken exactly as prescribed and recommended by your doctor or pharmacist.
  • Harvoni can be taken with or without food.
  • Harvoni is often taken orally once daily as tablets or pellets for 8 to 12 weeks, depending on your prescription.
  • Harvoni should be taken at the same time every day.
  • Harvoni tablets should be swallowed as a whole with one glass of water. Do not break, split, crush, or chew the tablets.
  • Harvoni oral pellets can be administered by sprinkling and mixing it with non-acidic soft food or swallowing it without food. Examples of non-acidic soft foods include mashed potatoes, ice cream, chocolate syrup, or puddings.
  • Any leftover mixtures of Harvoni pellets should be discarded and not stored for later use.
  • If you forget to take a dose, take it as soon as you remember. Two dosages should never be taken on the same day.

与专家交谈

关于共付额援助
安排咨询

药物相互作用

The following drugs should not be taken with Harvoni because they may interfere with the drug’s reaction or slow its removal from your body.

  • Amiodarone
  • Flibanserin
  • Rosuvastatin
  • 利福平
  • 苯妥英
  • 苯巴比妥
  • 卡马西平
  • Primidone

Harvoni Side Effects

Harvoni patient suffering from cough as a side effect

Most of Harvoni’s side effects are minor and disappear as your body adjusts to the medication. But if the side effects become severe or persistent, consult your doctor immediately.

Common side effects include: 

  • 恶心
  • 腹泻 
  • 头痛
  • 咳嗽
  • Sleep disturbances
  • 气促
  • 肌肉疼痛
  • 疲劳

严重的副作用包括: 

  • Swelling of the face, throat, or tongue
  • Rashes
  • Severe dizziness
  • 过敏反应
  • Trouble breathing

Alcohol use while taking Harvoni may increase the chance of side effects and exacerbate liver inflammation and scarring.

力量

Harvoni comes in two oral dosage forms: pellets and tablets.

Tablets come in the following strengths:

  • 90 mg/400 mg (This strength contains 90 mg of ledipasvir and 400 mg sofosbuvir.)
  • 45 mg/200 mg (This strength contains 45 mg ledipasvir and 200 mg sofosbuvir.)

Pellets come in the following strengths:

  • 45 mg/200 mg (This strength contains 45 mg ledipasvir and 200 mg sofosbuvir.)
  • 33.75 mg/150 mg (This strength contains 33.75 mg ledipasvir and 150 mg sofosbuvir.)

Dosage Information

The recommended dose for adults is one 90 mg ledipasvir/400 mg sofosbuvir given once daily.

The dose for children is based on body weight: 

  • Children with a body weight of less than 35 kg with hepatitis C virus are given 45 mg/200 mg once daily.
  • Children weighing 35 kg or more are given a 90 mg/400 mg dose of Harvoni once daily.

获得共付额援助

经济援助
(877) 778-0318

How Much Does Harvoni Cost?

The cost of Harvoni depends on several factors, including:

  • The type of pharmacy and its location.
  • The duration of your treatment.
  • The dose and dosage form of Harvoni prescribed by your doctor.
  • Whether the price of the Harvoni drug is covered by your health insurance.

On average, the cost of Harvoni is approximately $65,000 for an 8-week treatment, $98,500 for a 12-week treatment, and $197,000 for a 24-week treatment without insurance. 经济援助 is available for those who cannot afford the medication. 

常见问题解答

Does Harvoni completely cure hepatitis C?

Yes. The cure rate of Harvoni drug is around 94% to 99% when you don’t have any other severe disease or complications. After 12 weeks of treatment, in most cases, there is no virus seen in the patient’s bloodstream.

How long is the treatment?

The duration of Harvoni treatment depends on the severity of the patient’s condition, the amount of hepatitis C virus present in the bloodstream of the patient, and whether or not the patient has cirrhosis with hepatitis C. Harvoni medication is prescribed once daily for approximately 8 to 24 weeks of treatment.

此信息不能替代医疗建议或治疗。在开始任何新的治疗之前,请咨询您的医生或医疗保健提供者,了解您的医疗状况。AmeriPharma® Specialty Care 对所提供的信息或由此做出的任何诊断或治疗不承担任何责任,也不对其内容的可靠性负责。AmeriPharma® Specialty Care 并非运营此处列出的所有网站/组织,也不对其内容的可用性或可靠性负责。这些列表并不暗示或构成 AmeriPharma® Specialty Care 的认可、赞助或推荐。本网页可能包含对品牌处方药的引用,这些处方药是与 AmeriPharma® Specialty Care 无关的制药商的商标或注册商标。
医学审核人 Martina Mikail 博士,药学博士

Martina Mikail 博士(药学博士)出生于埃及,在宾夕法尼亚州和加利福尼亚州长大。她于2022年5月毕业于马歇尔·B·凯彻姆大学。Mikail 博士曾荣获美国邮政署(USPS)领导力奖和美国医疗保健协会(CSHP)领导力奖,并且是 CSHP、ASHP 和 APhA 的活跃成员。她工作中最有成就感的部分是为患者提供用药教育和咨询。闲暇时,她喜欢烹饪、陪伴家人和阅读。

联系我们

使用下方符合 HIPAA 标准的表格申请续药。如果您对药物或用药方法有任何疑问,请访问“联系我们”页面或致电 (877) 778-0318.

HIPAA Compliant

提交即表示您同意 AmeriPharma 的 使用条款, 隐私政策, 和 隐私惯例通知

zh_CNChinese